COL4A1
Collagen alpha-1(IV) chain
Also known as: CO4A1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P02462
- Gene
- COL4A1
- Ensembl
- ENSG00000187498
- Chromosome
- 13
- Canonical length
- 1669 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins
- Secretome location
- Secreted to extracellular matrix
OverviewNCBI Gene
This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
Canonical amino-acid sequenceUniProt
1669 residues, UniProt reviewed canonical sequence.
>P02462|COL4A1
1 MGPRLSVWLL LLPAALLLHE EHSRAAAKGG CAGSGCGKCD CHGVKGQKGE RGLPGLQGVI
61 GFPGMQGPEG PQGPPGQKGD TGEPGLPGTK GTRGPPGASG YPGNPGLPGI PGQDGPPGPP
121 GIPGCNGTKG ERGPLGPPGL PGFAGNPGPP GLPGMKGDPG EILGHVPGML LKGERGFPGI
181 PGTPGPPGLP GLQGPVGPPG FTGPPGPPGP PGPPGEKGQM GLSFQGPKGD KGDQGVSGPP
241 GVPGQAQVQE KGDFATKGEK GQKGEPGFQG MPGVGEKGEP GKPGPRGKPG KDGDKGEKGS
301 PGFPGEPGYP GLIGRQGPQG EKGEAGPPGP PGIVIGTGPL GEKGERGYPG TPGPRGEPGP
361 KGFPGLPGQP GPPGLPVPGQ AGAPGFPGER GEKGDRGFPG TSLPGPSGRD GLPGPPGSPG
421 PPGQPGYTNG IVECQPGPPG DQGPPGIPGQ PGFIGEIGEK GQKGESCLIC DIDGYRGPPG
481 PQGPPGEIGF PGQPGAKGDR GLPGRDGVAG VPGPQGTPGL IGQPGAKGEP GEFYFDLRLK
541 GDKGDPGFPG QPGMPGRAGS PGRDGHPGLP GPKGSPGSVG LKGERGPPGG VGFPGSRGDT
601 GPPGPPGYGP AGPIGDKGQA GFPGGPGSPG LPGPKGEPGK IVPLPGPPGA EGLPGSPGFP
661 GPQGDRGFPG TPGRPGLPGE KGAVGQPGIG FPGPPGPKGV DGLPGDMGPP GTPGRPGFNG
721 LPGNPGVQGQ KGEPGVGLPG LKGLPGLPGI PGTPGEKGSI GVPGVPGEHG AIGPPGLQGI
781 RGEPGPPGLP GSVGSPGVPG IGPPGARGPP GGQGPPGLSG PPGIKGEKGF PGFPGLDMPG
841 PKGDKGAQGL PGITGQSGLP GLPGQQGAPG IPGFPGSKGE MGVMGTPGQP GSPGPVGAPG
901 LPGEKGDHGF PGSSGPRGDP GLKGDKGDVG LPGKPGSMDK VDMGSMKGQK GDQGEKGQIG
961 PIGEKGSRGD PGTPGVPGKD GQAGQPGQPG PKGDPGISGT PGAPGLPGPK GSVGGMGLPG
1021 TPGEKGVPGI PGPQGSPGLP GDKGAKGEKG QAGPPGIGIP GLRGEKGDQG IAGFPGSPGE
1081 KGEKGSIGIP GMPGSPGLKG SPGSVGYPGS PGLPGEKGDK GLPGLDGIPG VKGEAGLPGT
1141 PGPTGPAGQK GEPGSDGIPG SAGEKGEPGL PGRGFPGFPG AKGDKGSKGE VGFPGLAGSP
1201 GIPGSKGEQG FMGPPGPQGQ PGLPGSPGHA TEGPKGDRGP QGQPGLPGLP GPMGPPGLPG
1261 IDGVKGDKGN PGWPGAPGVP GPKGDPGFQG MPGIGGSPGI TGSKGDMGPP GVPGFQGPKG
1321 LPGLQGIKGD QGDQGVPGAK GLPGPPGPPG PYDIIKGEPG LPGPEGPPGL KGLQGLPGPK
1381 GQQGVTGLVG IPGPPGIPGF DGAPGQKGEM GPAGPTGPRG FPGPPGPDGL PGSMGPPGTP
1441 SVDHGFLVTR HSQTIDDPQC PSGTKILYHG YSLLYVQGNE RAHGQDLGTA GSCLRKFSTM
1501 PFLFCNINNV CNFASRNDYS YWLSTPEPMP MSMAPITGEN IRPFISRCAV CEAPAMVMAV
1561 HSQTIQIPPC PSGWSSLWIG YSFVMHTSAG AEGSGQALAS PGSCLEEFRS APFIECHGRG
1621 TCNYYANAYS FWLATIERSE MFKKPTPSTL KAGELRTHVS RCQVCMRRTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against COL4A1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.67
- Highest tissue expression
- 846 nTPM
Expression across tissuesHPA
Tissue
- placenta: 846 nTPM
- adipose tissue: 327 nTPM
- smooth muscle: 292 nTPM
- blood vessel: 213 nTPM
- appendix: 128 nTPM
- breast: 123 nTPM
Single-cell type
- extravillous trophoblasts: 1,310 nCPM
- pericytes: 1,138 nCPM
- hepatic stellate cells: 988 nCPM
- adipocytes: 940 nCPM
- vascular smooth muscle cells: 638 nCPM
- fibroblasts: 574 nCPM
Immune cell
- neutrophil: 0.3 nTPM
- basophil: 0.2 nTPM
- eosinophil: 0.1 nTPM
- classical monocyte: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- thalamus: 34 nTPM
- hippocampal formation: 30 nTPM
- amygdala: 26 nTPM
- medulla oblongata: 23 nTPM
- choroid plexus: 23 nTPM
- cerebral cortex: 20 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about COL4A1.
Disease | AllUniProt
Conditions COL4A1 is implicated in, by any mechanism.
- Hereditary angiopathy with nephropathy aneurysms and muscle cramps (HANAC) MIM:611773
- Brain small vessel disease 1 with or without ocular anomalies (BSVD1) MIM:175780
- Intracerebral hemorrhage (ICH) MIM:614519
- Tortuosity of retinal arteries (RATOR) MIM:180000
- Schizencephaly (SCHZC) MIM:269160
- Microangiopathy and leukoencephalopathy, pontine, autosomal dominant (PADMAL) MIM:618564
Disease | GeneticClinVar
404 pathogenic / likely-pathogenic of 2,916 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Brain small vessel disease 1 with or without ocular anomalies
- Autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome
- Microangiopathy and leukoencephalopathy, pontine, autosomal dominant
- Hemorrhage, intracerebral, susceptibility to
- Retinal arterial tortuosity
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.13
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.02
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- basement membrane organization
- blood vessel morphogenesis
- brain development
- branching involved in blood vessel morphogenesis
- cellular response to amino acid stimulus
- collagen fibril organization
- collagen-activated tyrosine kinase receptor signaling pathway
- epithelial cell differentiation
- neuromuscular junction development
- renal tubule morphogenesis
- retinal blood vessel morphogenesis
Molecular functions
- extracellular matrix structural constituent
- extracellular matrix structural constituent conferring tensile strength
- platelet-derived growth factor binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of COL4A1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads COL4A1 as an antibody target. Whether an autoantibody or antibody against COL4A1 could matter depends on whether native COL4A1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
COL4A1 is annotated as secreted, so native COL4A1 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label COL4A1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...